Evaluation of class 1, 2 and 3 integrons among multidrug resistant isolates of acinetobacter baumannii
Keywords:
integrons, Acinetobacter baumannii, integron classes, Multidrug Resistant Isolates of Acinetobacter baumanniiAbstract
The goal of this study was to determine the prevalence of class 1, 2, and 3 integrons in clinical Acinetobacter baumannii isolates from hospitalized patients. A total of 100 A. baumannii isolates were collected from several Imam Khomeini hospitals in Ilam, Iran. A. baumannii was discovered by traditional biochemical research. Following that, PCR was employed to detect several integron classes. Biochemical testing was used to identify Acinetobacter species. The samples obtained from patients (patients aged 21 to 69 years old, including 55 males and 45 women): Acinetobacter baumannii was found in 100 samples, Acinetobacter lufii in 25, and other Acinetobacter species in 12. 42 samples from the critical care unit were separated, 28 from the infectious department, 23 from the emergency department, and 7 from other departments. Furthermore, 44 blood samples, 23 trachea samples, 11 wound samples, 10 urine samples, and 12 unknown samples were isolated. Class 1 Integrons were found in 87 of 100 isolates, Class 2 Integrons in 74 of 100 isolates, and Class 3 Integrons in none of the isolates.
Downloads
References
Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538-82.
Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012;3(3):243-50.
Marks LR, Reddinger RM, Hakansson AP. Biofilm formation enhances fomite survival of Streptococcus pneumoniae and Streptococcus pyogenes. Infection and immunity. 2014;82(3):1141-6.
Jaisankar AI, Girija AS, Gunasekaran S, Priyadharsini JV. Molecular characterisation of csgA gene among ESBL strains of A. baumannii and targeting with essential oil compounds from Azadirachta indica. Journal of King Saud University-Science. 2020;32(8):3380-7.
Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile genetic elements associated with antimicrobial resistance. Clinical microbiology reviews. 2018;31(4):e00088-17.
Ike W, Adeniyi BA, Peters JE. Class 1 Integrons and Associated Gene Cassettes in Multidrug Resistant Acinetobacter baumannii from Southwest Nigeria: A Tertiary-Hospitals Study. Nigerian Journal of Pharmaceutical and Applied Science Research. 2021;10(1):61-9.
Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi F. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect Dis. 2019;19(1):1-9.
Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrobial Resistance & Infection Control. 2018;7(1):1-17.
Kumar SG, Adithan C, Harish B, Sujatha S, Roy G, Malini A. Antimicrobial resistance in India: A review. Journal of natural science, biology, and medicine. 2013;4(2):286.
Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert review of anti-infective therapy. 2013;11(3):297-308.
De Oliveira DM, Forde BM, Kidd TJ, Harris PN, Schembri MA, Beatson SA, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):e00181-19.
Lucidi M, Runci F, Rampioni G, Frangipani E, Leoni L, Visca P. New shuttle vectors for gene cloning and expression in multidrug-resistant Acinetobacter species. Antimicrob Agents Chemother. 2018;62(4):e02480-17.
Tewari R, Chopra D, Wazahat R, Dhingra S, Dudeja M. Antimicrobial susceptibility patterns of an emerging multidrug resistant nosocomial pathogen: Acinetobacter baumannii. The Malaysian journal of medical sciences: MJMS. 2018;25(3):129.
Sato Y, Unno Y, Miyazaki C, Ubagai T, Ono Y. Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages. Sci Rep. 2019;9(1):1-12.
Kumar S, Anwer R, Azzi A. Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii. Microorganisms. 2021;9(10):2104.
Liebchen U, Paal M, Jung J, Schroeder I, Frey L, Zoller M, et al. Therapeutic drug monitoring-guided high dose meropenem therapy of a multidrug resistant Acinetobacter baumannii-A case report. Respiratory medicine case reports. 2020;29:100966.
Yadav SK, Bhujel R, Hamal P, Mishra SK, Sharma S, Sherchand JB. Burden of multidrug-resistant Acinetobacter baumannii infection in hospitalized patients in a tertiary care hospital of Nepal. Infection and drug resistance. 2020;13:725.
He H, Li M, Guo Y, Luo L, Bhattarai R, Li W. Intracranial Infection Caused by Multidrug-resistant Acinetobacter baumannii. Nepal Journal of Neuroscience. 2021;18(4):59-63.
Taherikalani M, Maleki A, Sadeghifard N, Mohammadzadeh D, Soroush S, Asadollahi P, et al. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Polish Journal of Microbiology. 2011;60(2):169.
Fluit A, Schmitz F. Class 1 integrons, gene cassettes, mobility, and epidemiology. European Journal of Clinical Microbiology and Infectious Diseases. 1999;18(11):761-70.
Taherikalani M, Maleki A, Sadeghifard N, Mohammadzadeh D, Soroush S, Asadollahi P, et al. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Polish Journal of Microbiology. 2011;60(2):169.
Antunes L, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathogens and disease. 2014;71(3):292-301.
Halaji M, Rezaei A, Zalipoor M, Faghri J. Investigation of class I, II, and III integrons among Acinetobacter baumannii isolates from hospitalized patients in Isfahan, Iran. Oman Medical Journal. 2018;33(1):37.
Aliramezani A, Soleimani M, Fard RMN, Nojoomi F. Virulence determinants and biofilm formation of Acinetobacter baumannii isolated from hospitalized patients. Germs. 2019;9(3):148.
Nourbakhsh F, Nourbakhsh V, Jafakesh MT. Prevalence of class I, II and III integrons in the antibiotic-resistant isolates of A. baumannii detected from patients hospitalized in medical centers of Shahrekord. KAUMS Journal (FEYZ). 2016;20(5):461-8.
Kempf M, Rolain J-M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. International journal of antimicrobial agents. 2012;39(2):105-14.
Pogue JM, Mann T, Barber KE, Kaye KS. Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management. Expert review of anti-infective therapy. 2013;11(4):383-93.
28.Boucher Y, Labbate M, Koenig JE, Stokes H. Integrons: mobilizable platforms that promote genetic diversity in bacteria. Trends in microbiology. 2007;15(7):301-9.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
